Startups
Explore Curapath's support from preclinical to commercialization for non-viral drug delivery. Trust our expertise to transform patients' lives.
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 18, 2026 | Macro Biologics IND Accepted by FDA for Amicidin-α Surgical Gel’s Phase 1 Clinical Trial | Amicidin-α Surgical Gel is designed to protect the vulnerable tissues of surgical and traumatic wounds and reduce the risk of infection Our top priority is to create a new generation of advanced biomaterials that can protect at-risk patient... |
| Apr 15, 2026 | Curapath and Nacalai Tesque Partner to Expand Access to next generation Polymers and PEG-Free Shielding Lipids in Japan | Partnership expands access in Japan to PEG-free shielding lipids and polymers for LNPs and advanced drug delivery applications. VALENCIA, SPAIN, April 15, 2026 /EINPresswire.com/ -- Two companies focused on advancing drug delivery technolog... |
| Oct 2, 2025 | Curapath and Iris Biotech Partner to Provide Wider Access to Innovative Excipients for Drug Delivery | PATERNA, VALENCIA, SPAIN, October 2, 2025 /EINPresswire.com/ -- Curapath, a leading innovator in the design and manufacturing of polymer and 𝗽𝗼𝗹𝘆𝗺𝗲𝗿 𝗮𝗻𝗱 𝗹𝗶𝗽𝗶𝗱-𝗯𝗮𝘀𝗲𝗱 𝗱𝗿𝘂𝗴 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝘀𝘆𝘀𝘁𝗲𝗺𝘀, is proud to announce a strategic partnership with Ir... |
| Jul 1, 2025 | Macro Biologics and Curapath Expand Strategic Partnership to Manufacture Advanced Biomaterials for Healthcare and Beyond | VALENCIA, COMUNIDAD VALENCIANA, SPAIN, July 1, 2025 /EINPresswire.com/ -- Macro Biologics, Inc. , a US-based company (Carlsbad, Carlifornia) at the intersection of materials science and biotechnology, develops innovative products for health... |
| Oct 7, 2024 | Curapath and Certest Join Forces to Offer Next-Generation Lipid Nanoparticles Formulations with Proprietary Excipients | VALENCIA & ZARAGOZA, SPAIN, October 7, 2024 /EINPresswire.com/ -- Curapath, a leading innovator in the manufacturing of novel lipid and polymer excipients, nanoparticle formulations and innovative polymer conjugates, and Certest Biotech... |
| Feb 14, 2024 | Curapath Strengthens Partnership in Breakthrough Genetic Medicine with Multiyear Development and Manufacturing Agreement | VALENCIA, SPAIN, February 14, 2024 /EINPresswire.com/ -- Curapath, a leader in the development and custom manufacturing of polymer- and lipid-based delivery systems for advanced therapies, has entered into a multiyear Development and Manufa... |
Reviews 0
FAQ about Leading CDMO
What has the press written about Leading CDMO?
Parsers VC has collected 7 articles mentioning Leading CDMO, among them “Macro Biologics IND Accepted by FDA for Amicidin-α Surgical Gel’s Phase 1 Clinical Trial” (Jun 18, 2026) and “Curapath and Nacalai Tesque Partner to Expand Access to next generation Polymers and PEG-Free Shielding Lipids in Japan” (Apr 15, 2026).
Is Leading CDMO still active?
Yes, Leading CDMO is active; its latest activity on Parsers VC dates from Sep 17, 2026.